Solid Biosciences Inc (SLDB)

Etorro trading 970x250
Solid Biosciences Inc (SLDB) Logo

About Solid Biosciences Inc

Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company’s lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients’ muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. Address: 141 Portland Street, Cambridge, MA, United States, 02139

Solid Biosciences Inc News and around…

Latest news about Solid Biosciences Inc (SLDB) common stock and company :

REGENXBIO (RGNX) DMD Gene Therapy Gets Orphan Drug Status
23 Nov, 2021 Yahoo! Finance

REGENXBIO (RGNX) is developing a gene therapy candidate, RGX-202, for treating DMD, which is currently in the pre-clinical stage. An IND application is expected by the end of 2021.

What Type Of Shareholders Make Up Solid Biosciences Inc.'s (NASDAQ:SLDB) Share Registry?
18 Nov, 2021 Yahoo! Finance

The big shareholder groups in Solid Biosciences Inc. ( NASDAQ:SLDB ) have power over the company. Institutions will...

Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Now
15 Nov, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's Pre-Market Session
08 Nov, 2021 FinancialContent

Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The ...

5 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
05 Nov, 2021 FinancialContent
Analysts Forecast 12% Upside For The Holdings of VTWV
04 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 2000 Value ETF (VTWV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $170.63 per unit.

Solid Biosciences Inc. (SLDB) Reports Q3 Loss, Tops Revenue Estimates
03 Nov, 2021 Yahoo! Finance

Solid Biosciences Inc. (SLDB) delivered earnings and revenue surprises of 15.79% and 7.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results
03 Nov, 2021 Yahoo! Finance

- Continued focus on advancing SGT-001 includes additional patient dosings in IGNITE DMD expected to begin in Q4 2021 - - Continued progress with SGT-003; Solid’s next-generation Duchenne gene therapy program demonstrates enhanced muscle tropism and microdystrophin expression - - Company ends Q3 with approximately $229.8 million in cash and investments; cash runway into Q2 2023 - CAMBRIDGE, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company fo

Pathway Development Consortium Releases Draft White Paper to Facilitate AAV Gene Therapy Development
02 Nov, 2021 Yahoo! Finance

- Draft white paper published today by the Pathway Development Consortium provides a framework for applying the accelerated approval pathway to AAV gene therapy development - - Pathway Development Consortium is building a collaboration of patients, industry, regulators, academia, payers and other stakeholders - WASHINGTON, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The Pathway Development Consortium (PDC), a new public-private collaboration founded by REGENXBIO Inc. (Nasdaq: RGNX) and Solid Biosciences I

Solid Biosciences to Participate at the Jefferies Gene Therapy/Editing Summit
21 Oct, 2021 Yahoo! Finance

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Ilan Ganot, Co-Founder, President and Chief Executive Officer, and Carl Morris, PhD, Chief Scientific Officer, will participate in a fireside chat at the Jefferies Gene Therapy/Editing Summit on Thursday, October 28, 2021 at 2:00 p.m. ET. A live webcast of this fireside chat wi

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Analysts Forecast 18% Upside For IWN
04 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Value ETF (IWN), we found that the implied analyst target price for the ETF based upon its underlying holdings is $192.86 per unit.

Solid Biosciences and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership
04 Oct, 2021 FinancialContent

Solid and Forge Announce Viral Vector Contract Development and cGMP Manufacturing Partnership

Vanadium One Iron Provides Corporate Update
01 Oct, 2021 Yahoo! Finance

TORONTO, ON / ACCESSWIRE / October 1, 2021 / Vanadium One Iron Corp. (the "Company") (TSXV:VONE), announces that as a result of a review by staff of the Ontario Securities Commission, the Company is issuing the following news release regarding disclosure at the Mont Sorcier Iron and Vanadium Project.

7 Best Penny Stocks to Buy on the Nasdaq for October
29 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks have a place in every portfolio when adjusted for risk. These 7 have the added safety of a Nasdaq listing. The post 7 Best Penny Stocks to Buy on the Nasdaq for October appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Solid Biosciences Reports Additional Pulmonary Function Results from the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001
29 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's Pre-Market Session
24 Sep, 2021 FinancialContent

Gainers Cellect Biotechnology (NASDAQ:APOP) stock moved upwards by 251.16% to $21.07 during Friday's pre-market ...

Solid Biosciences Stock Gains After Duchenne Dystrophy Gene Therapy Data
23 Sep, 2021 FinancialContent

Solid Biosciences Inc(NASDAQ: SLDB)reports 1.5-year functional dataand patient-reported outcome measures in the ...

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
23 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
23 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We're diving back into the stock market again today with a look at the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

24 Stocks Moving in Thursday's Pre-Market Session
23 Sep, 2021 FinancialContent

Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company ...

Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001
23 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's After-Market Session
22 Sep, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) shares rose 21.54% to $25.1 during Wednesday's after-market session. ...

Implied Volatility Surging for Solid Biosciences (SLDB) Stock Options
22 Sep, 2021 Yahoo! Finance

Investors need to pay close attention to Solid Biosciences (SLDB) stock based on the movements in the options market lately.

Space Stocks: 12 Things for Spire Global Investors to Know as SPIR Stock Rockets Today
21 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Spire Global (SPIR) stock is on the rise Tuesday alongside heavy trading despite a lack of news from the space satellite company today. The post Space Stocks: 12 Things for Spire Global Investors to Know as SPIR Stock Rockets Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

SLDB Stock Alert: Dear Solid Biosciences Investors, Mark Your Calendar for Sept. 23!
21 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Solid Biosciences (SLDB) stock is rising higher today as investors prepare for an update from the company later this week. The post SLDB Stock Alert: Dear Solid Biosciences Investors, Mark Your Calendar for Sept. 23! appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

32 Stocks Moving In Tuesday's Mid-Day Session
21 Sep, 2021 FinancialContent

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 177.4% to $39.83. Helbiz Media, the media arm of Helbiz announced a deal with ...

Why Shares of Solid Biosciences Are Jumping Today
21 Sep, 2021 FinancialContent

Shareholders are expecting to finally get good news.

Solid Biosciences to Provide Update on Long-Term Outcomes Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001
20 Sep, 2021 FinancialContent

Solid Biosciences Inc (SLDB) is a NASDAQ Common Stock listed in , ,

970x250